Telik Cash Flow - Quarterly (OTCMKTS:MBVX)

Add to My Stocks
$0.4 $0.03 (6.98%) MBVX stock closing price Sep 17, 2018 (Closing)

For analyzing any company like Telik from an investment perspective, its important to check the cash flow statement. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For Telik profits one has to check the income statement and for Telik debt one has to check the balance sheet. Telik saw a cash impact of $9.4M from the issuance of MBVX shares. The cash flow statement helps in the Telik stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Telik had an outflow of $-10.99M from operating activities, $7.92M inflow due to financing activities, and $-0.02M outflow due to investing activities till 2017 Q4.

View and download details of Telik cash flows for latest & last 40 quarters
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Net Income Cash Flow
-19.02M-14.42M-11.34M-5.35M-17.66M-12.55M-8.19M-4.4M-18.1M
Depreciation Depletion Amortization Cash-Flow---------
Net Increase (Decrease) in Assets Liabilities--1.45M---1.09M--0.18M1.15M
Cash From (used in) Discontinued Operations---------
Other Adjustments Net7.4M4.75M3.56M1.08M4.56M3.62M2.55M1.59M6.4M
Net Cash from (used by) Operating Activities
-10.99M-8.7M-6.02M-3.17M-12.36M-9.62M-5.22M-2.91M-10.52M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.02M---0.56M-0.41M-0.31M-0.15M-0.07M
Acquisition Disposition of Subsidiaires---------
Increase (Decrease) in Investments---------
Other Cash Inflow (Outflow) from Investment Activities---------
Net Cash from (used by) Investment Activities
-0.02M-0.02M---0.56M-0.41M-0.31M-0.15M-0.07M
Issuance (Purchase) of Equity Shares9.4M8.84M4.52M-8.56M8.57M--13.21M
Issuance (Repayment) of Debt Securities-1.4M-0.98M-0.55M--0.01M-0.01M---
Increase (Decrease) in Bank & Other Borrowings--0.06M--0.13M--0.1M---
Payment of Dividends & Other Cash Distributions---------
Other Cash from (used by) Financing Activities-0.08M--0.06M-0.06M4.26M4.43M4.43M4.61M-
Net Cash from (used by) Financing Activities
7.92M7.79M3.89M-0.2M12.82M12.89M4.42M4.61M13.21M
Effect of Exchange Rate Changes on Cash---------
Net Change in Cash & Cash Equivalents
-3.09M-0.92M-2.13M-3.38M-0.1M2.85M-1.11M1.54M2.6M
Cash & Equivalents at Beginning of Year4.08M1.47M-4.74M9.04M7.76M12.25M50.56M41.64M
Cash & Equivalents at Year End-3.05M1.84M-3.97M6.94M2.97M5.62M4.08M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Click here to view our Immunomedics financial analysis

While Telik stock price history provides the price history of a stock, Telik stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Telik has cash of $- on hand. A healthy amount of cash on hand is necessary for any company. Cash has an opportunity cost associated with it, and too much cash in bank may mean that the firm has no or limited growth plans. Hence its important to track the Net Change in Cash and Cash Equivalents along with the Telik stock price.
  • Cash Flow from operating activities: This is the cash that the company receives from ongoing operations. Telik lost $-10.99M cash from operations. It is important to check this to see where the company is getting its money from.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.02M for MBVX till last quarter 2017 Q4 report.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. Telik earned $7.92M from financing activities,in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For Telik Cash Flow

Quarterly Cash Flow Statements For MABVAX THERAPEUTIC COM USD0.01 Peers

Immunomedics cash flow, Integrated Biopharma cash flow, Navidea Biopharma cash flow, Bio Blast Pharma cash flow